Landec Corporation to Present at the 22nd Annual ICR Conference
January 07 2020 - 4:05PM
Landec Corporation (Nasdaq: LNDC), a diversified health and
wellness company with two operating businesses, Curation Foods,
Inc. and Lifecore Biomedical, Inc., announced today that Dr. Albert
Bolles, the Company's president and chief executive officer, and
Brian McLaughlin, interim chief financial officer, will be
presenting at the 22nd Annual ICR Conference, to be held January
13-15, 2020, at the Grande Lakes Orlando Resort in
Florida.
The Landec investor presentation is scheduled
for Monday, January 13, 2020, at 9:30AM ET and can be accessed via
webcast and hosted at the “Events & Presentations” section of
the Company's investor relations website: ir.landec.com.
About Landec CorporationLandec
Corporation (Nasdaq: LNDC) is a leading innovator of diversified
health and wellness solutions with two operating businesses:
Curation Foods, Inc. and Lifecore Biomedical, Inc. Landec
designs, develops, manufactures, and sells products for the food
and biopharmaceutical industry. Curation Foods is focused on
innovating and distributing plant-based foods with 100% clean
ingredients to retail, club and foodservice channels throughout
North America. Curation Foods is able to maximize product freshness
through its geographically dispersed family of growers,
refrigerated supply chain and patented BreatheWay® packaging
technology. Curation Foods brands include Eat Smart® fresh
packaged vegetables and salads, O Olive Oil &
Vinegar® premium artisan products, and Yucatan® and Cabo
Fresh® avocado products. Lifecore Biomedical is a fully integrated
contract development and manufacturing organization (CDMO) that
offers highly differentiated capabilities in the development, fill
and finish of sterile, injectable pharmaceutical products in
syringes and vials. As a leading manufacturer of premium,
injectable grade Hyaluronic Acid, Lifecore brings 35 years of
expertise as a partner for global and emerging biopharmaceutical
and medical device companies across multiple therapeutic categories
to bring their innovations to market. For more information about
the Company, visit Landec’s website at www.landec.com.
Contact
Information: |
|
Investor
Relations: |
Jeff Sonnek |
(646) 277-1263 |
jeff.sonnek@icrinc.com |
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Landec (NASDAQ:LNDC)
Historical Stock Chart
From Sep 2023 to Sep 2024